# OnCo record cambria (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/cambria/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "cambria", "NCT05952557" ;
  schema:name "CAMBRIA-1 & CAMBRIA-2"@en ;
  schema:description "CAMBRIA-1 and CAMBRIA-2 are two adjuvant trials enrolling close to 10,000 women with early hormone-receptor-positive breast cancer to test whether the oral oestrogen-receptor degrader camizestrant should replace today's adjuvant hormone tablets, either as a switch after two to five years or from the start. Results are awaited."@en ;
  schema:url <https://onco.cc/trials/cambria/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05952557> ;
  onco:status "active" ;
  onco:phase "3" ;
  schema:startDate "2023-10-05" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:technologies <https://onco.cc/technologies/endocrine-therapy/> ;
  onco:drugs <https://onco.cc/drugs/camizestrant/> ;
  onco:companies <https://onco.cc/companies/astrazeneca/> .